Obstetrics and Gynaecology
DRUG
REGISTRY OF PREGNANT WOMEN ADMITTED IN THE DEPT OF OBSTETRICS & GYNAECOLOGY OF
SETH GSMC & KEM HOSPITAL
Rationale:
As many as 35% of women are reported to be taking at least one drug during
pregnancy. It has been estimated that the average pregnant woman ingests 3.8 drugs
during the course of her pregnancy. Almost all drugs reach the fetus to a greater
or lesser extent despite the placental barrier.
The effects of drugs on the
fetus in terms of anomalies, developmental problems behavioural problems & problems
of psychosocial adjustment have been studied extensively in the Western population
However,
in India there is a paucity of such data. At KEMH it was felt that since it is
a well documented fact that pharmacokinetics of drugs differ in different population
groups, it is imperative that such data bases are compiled for the Indian population
as well. KEMH being a major referral center with a large annual workload it is
the appropriate place for such a registry.
Objectives:
Short term-
1. To formulate a database of drugs (over the counter
& prescription)
2. To compile statistics and draw inferences on the use of
various drugs.
Long term-
1. Formation of guidelines for the better
care of pregnant women.
Methodology:
A prospective descriptive study with data collection on structured data sheets
maintained in registers. The data was obtained from case papers & admission papers
of women who had delivered /aborted within the last 7 days of entry of data. Additional
information was obtained from the women themselves.
Proposal sent to ICMR HQRs in Sept. 2002. No grant received.
Salient
Findings:
This ongoing study was commenced in October 2001. It was stopped
for a short period due to shortage of staff. An interim analysis follows:-
No.
of deliveries / abortions in one unit : 1223
No. of women with anomalous fetuses
: 35
Analysis was considered in 2 parts
1. Analysis of women
with anomalous fetuses/neonates
2. Analysis of women on specific drugs (medication)
1. Women with
anomalous fetuses/neonates
a)
The maternal age and parity did not have any statistical significance.
b)
The abnormal neonates weighed on an average less than and were born earlier than
the normal ones.
c) Of 1223 women 35 were found to have anomalous fetuses.
| - | Fetuses
with anomalies | Fetuses
w/o anomalies | Total |
| Women on specific medication | 7
| 178
| 185 |
| Women on routine medication | 28
| 1010
| 1038 |
| Total | 35
| 1188
| 1223 |
d)
The anomalies detected were Cranial (12), GI Tract (5), Limb (6) and others (13).
The
commonest anomaly was Hydrocephalus. None of the anomalies detected were known
to have an association with medication ingested. None of the anomalies detected
were known to have a specific association with the medication ingested
2.
Analysis of women on specific drugs (medication)
Analysis
of the women on specific medication | |||
| Drug | Total
No. of Patients | Gest.
Age (in weeks) | Weight
(gms) |
| Aldomet | 56
| 34.8
± 3.56 | 1916
± 751 |
| Aspirin | 52
| 36.5
± 3.48 | 2371
± 664 |
| Depin | 50
| 34.7
± 3.81 | 1928
± 689 |
| Digoxin | 06
| 34.2
± 2.48 | 1881
± 251 |
| Atenolol | 12
| 36.2
± 2.58 | 2182
± 298 |
| Lasix | 15
| 36.5
± 2.68 | 2273
± 469 |
a) Data was analyzed to study the relationship between specific medication used and the average gestational age and average birth weight. There was no significant difference in gestational age. However, there was a significant difference in neonatal weights.
In our study Atenolol did not appear to cause growth restriction. It appears that the average birth weight is comparable when only of the drugs (Digoxin, Lasix, Depin & Aldoment) are used in PIH or RHD.
Status:
This study is ongoing and is now confined to women on specific medication
only and has been restarted from 1st July 2004.
1st July 2004 - 31st July
2005
Data from 2 units (Dr. Vinita Salvi & Dr. V.S. Raut)
Total No. of Deliveries-
3009
Total No. of Women on medication -133 (4.42%)
Total No. of women
with anomalous babies/fetuses- 32 (1.03%)
Total No. of women on specific medication
with anomalous babies/fetus - 05 (3.8%)
| Medication use by women who delivered anomalous babies/fetus | |
| Terbutaline | 2 |
| Aspirin | 2 |
| Aldomet | 1 |
| Salbutamol | 1 |
| Asthalin | 1 |
| Insulin | 1 |
| Information for Patients | Residency Training Programme | Laboratory Services | Surgical Services | Research | |
| Management Guidelines | Family Welfare | Message | Useful links | Alumni | Feedback |